metformin has been researched along with Aggression in 5 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Aggression: Behavior which may be manifested by destructive and attacking action which is verbal or physical, by covert attitudes of hostility or by obstructionism.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We present a case of psychosis associated with the menstrual cycle in a patient with polycystic ovary syndrome, a disorder typically characterized by anovulatory cycles, in whom the restoration of normal menstruation with use of metformine led to significant improvement of psychotic symptoms." | 7.74 | Metformine for psychosis associated with the menstrual cycle in a patient with polycystic ovary syndrome. ( Andreou, C; Karavatos, A; Syngelakis, M, 2008) |
| "The purpose of this manuscript is to review the evidence generated by clinical trials of pharmaceuticals in autism spectrum disorder (ASD), describe challenges in the conduct of such trials, and discuss future directions RECENT FINDINGS: Clinical trials in ASD have produced several compounds to adequately support the pharmacological treatment of associated symptom domains: attention deficit hyperactivity disorder (methylphenidate, atomoxetine, and alpha agonists), irritability/aggression (risperidone and aripiprazole), sleep (melatonin), and weight gain associated with atypical antipsychotic use (metformin)." | 4.98 | Clinical trials in autism spectrum disorder: evidence, challenges and future directions. ( Anagnostou, E, 2018) |
| " We present a case of psychosis associated with the menstrual cycle in a patient with polycystic ovary syndrome, a disorder typically characterized by anovulatory cycles, in whom the restoration of normal menstruation with use of metformine led to significant improvement of psychotic symptoms." | 3.74 | Metformine for psychosis associated with the menstrual cycle in a patient with polycystic ovary syndrome. ( Andreou, C; Karavatos, A; Syngelakis, M, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagy, LR | 1 |
| Rice, T | 1 |
| Coffey, BJ | 2 |
| Anagnostou, E | 1 |
| MacLaren, RD | 1 |
| Wisniewski, K | 1 |
| MacLaren, C | 1 |
| Salau, M | 1 |
| Adam, B | 1 |
| Andreou, C | 1 |
| Syngelakis, M | 1 |
| Karavatos, A | 1 |
1 review available for metformin and Aggression
| Article | Year |
|---|---|
Clinical trials in autism spectrum disorder: evidence, challenges and future directions.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Aggression; Antipsychotic Agents; Aripipraz | 2018 |
4 other studies available for metformin and Aggression
| Article | Year |
|---|---|
Combined Topiramate and Metformin Pharmacotherapy for Second-Generation Antipsychotic-Induced Weight Gain in Pediatric Bipolar Disorder and Aggression.
Topics: Aggression; Antipsychotic Agents; Bipolar Disorder; Child; Humans; Metformin; Topiramate; Weight Gai | 2022 |
Environmental concentrations of metformin exposure affect aggressive behavior in the Siamese fighting fish, Betta splendens.
Topics: Aggression; Analysis of Variance; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Fishe | 2018 |
Metformin in an Adolescent with Significant Weight Gain.
Topics: Adolescent; Aggression; Antipsychotic Agents; Autism Spectrum Disorder; Humans; Hypoglycemic Agents; | 2015 |
Metformine for psychosis associated with the menstrual cycle in a patient with polycystic ovary syndrome.
Topics: Aggression; Female; Humans; Hypoglycemic Agents; Menstruation; Metformin; Polycystic Ovary Syndrome; | 2008 |